BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30035626)

  • 1. THE MANAGEMENT OF HYPERGLYCEMIA IN NONCRITICALLY ILL HOSPITALIZED PATIENTS TREATED WITH CONTINUOUS ENTERAL OR PARENTERAL NUTRITION.
    Vennard KC; Selen DJ; Gilbert MP
    Endocr Pract; 2018 Oct; 24(10):900-906. PubMed ID: 30035626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
    Hakeam HA; Mulia HA; Azzam A; Amin T
    JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin.
    Dickerson RN; Wilson VC; Maish GO; Croce MA; Minard G; Brown RO
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):506-16. PubMed ID: 22914894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Evaluation of Glycemic Control With Basal-Bolus or Neutral Protamine Hagedorn Insulin Regimens in Patients Receiving Continuous Enteral Nutrition Therapy in Medicine Wards.
    Hijaze D; Szalat A
    Nutr Clin Pract; 2017 Aug; 32(4):557-562. PubMed ID: 28760108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemia in noncritically ill patients receiving total parenteral nutrition: a multicenter study. (Study group on the problem of hyperglycemia in parenteral nutrition; Nutrition area of the Spanish Society of Endocrinology and Nutrition).
    Olveira G; Tapia MJ; Ocón J; Cabrejas-Gómez C; Ballesteros-Pomar MD; Vidal-Casariego A; Arraiza-Irigoyen C; Olivares J; Conde-García MC; García-Manzanares Á; Botella-Romero F; Quílez-Toboso RP; Matía P; Rubio MÁ; Chicharro L; Burgos R; Pujante P; Ferrer M; Zugasti A; Petrina E; Manjón L; Diéguez M; Carrera MJ; Vila-Bundo A; Urgelés JR; Aragón-Valera C; Sánchez-Vilar O; Bretón I; García-Peris P; Muñoz-Garach A; Márquez E; Del Olmo D; Pereira JL; Tous MC
    Nutrition; 2015 Jan; 31(1):58-63. PubMed ID: 25441588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hyperglycemia during enteral and parenteral nutrition therapy.
    Gosmanov AR; Umpierrez GE
    Curr Diab Rep; 2013 Feb; 13(1):155-62. PubMed ID: 23065369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition and Hyperglycemia Management in the Inpatient Setting (Meals on Demand, Parenteral, or Enteral Nutrition).
    Drincic AT; Knezevich JT; Akkireddy P
    Curr Diab Rep; 2017 Aug; 17(8):59. PubMed ID: 28664252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from intravenous insulin to subcutaneous long-acting insulin in critical care patients on enteral or parenteral nutrition.
    Ramos A; Zapata L; Vera P; Betbese AJ; Pérez A
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):552-556. PubMed ID: 29179857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures.
    Seisa MO; Saadi S; Nayfeh T; Muthusamy K; Shah SH; Firwana M; Hasan B; Jawaid T; Abd-Rabu R; Korytkowski MT; Muniyappa R; Antinori-Lent K; Donihi AC; Drincic AT; Luger A; Torres Roldan VD; Urtecho M; Wang Z; Murad MH
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2139-2147. PubMed ID: 35690929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): hyperglycemia and diabetes mellitus].
    Vaquerizo Alonso C; Grau Carmona T; Juan Díaz M;
    Med Intensiva; 2011 Nov; 35 Suppl 1():48-52. PubMed ID: 22309753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Insulin Degludec in Hospitalized Patients With and Without Type 2 Diabetes Requiring Parenteral/Enteral Nutrition: An Observational Study.
    Fatati G; Di Donato A; Grandone I; Menicocci P; Mirri E; Prosperini G; Scardapane M; Rossi MC; Palazzi M
    Adv Ther; 2018 Jun; 35(6):809-816. PubMed ID: 29777522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of glucose abnormalities in patients receiving total parenteral nutrition.
    Knapke CM; Owens JP; Mirtallo JM
    Clin Pharm; 1989 Feb; 8(2):136-44. PubMed ID: 2492913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Glucose Control in Noncritically Ill, Hospitalized Patients Receiving Parenteral and/or Enteral Nutrition: A Systematic Review.
    Laesser CI; Cumming P; Reber E; Stanga Z; Muka T; Bally L
    J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31261760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RISK FACTORS FOR HYPOGLYCEMIA IN INPATIENTS WITH TOTAL PARENTERAL NUTRITION AND TYPE 2 DIABETES: A POST HOC ANALYSIS OF THE INSUPAR STUDY.
    Olveira G; Abuín J; López R; Herranz S; García-Almeida JM; García-Malpartida K; Ferrer M; Cancer E; Luengo-Pérez LM; Álvarez J; Aragón C; Ocón MJ; García-Manzanares Á; Bretón I; Serrano-Aguayo P; Pérez-Ferre N; López-Gómez JJ; Olivares J; Arraiza C; Tejera C; Martín JD; Urioste-Fondo A; Abad ÁL; Alhambra MR; Zugasti A; Parra J; Torrejón S; Tapia MJ
    Endocr Pract; 2020 Jun; 26(6):604-611. PubMed ID: 32160049
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.
    Truong S; Park A; Kamalay S; Hung N; Meyer JG; Nguyen N; Momenzadeh A
    Nutr Clin Pract; 2019 Oct; 34(5):775-782. PubMed ID: 30693980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients.
    Doola R; Greer RM; Hurford R; Flatley C; Forbes JM; Todd AS; Joyce CJ; Sturgess DJ
    Clin Nutr; 2019 Aug; 38(4):1707-1712. PubMed ID: 30170779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Insulins in Critically Ill Patients Receiving Continuous Enteral Nutrition.
    Ni K; Hawkins RM; Smyth HL; Seggelke SA; Gibbs J; Lindsay MC; Kaizer LK; Low Wang CC
    Endocr Pract; 2024 Apr; 30(4):367-371. PubMed ID: 38307456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: hyperglycemia and diabetes mellitus.
    Vaquerizo Alonso C; Grau Carmona T; Juan Díaz M;
    Nutr Hosp; 2011 Nov; 26 Suppl 2():46-9. PubMed ID: 22411519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.